Groowe Groowe / Newsroom / CRL
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

CRL News

Charles River Laboratories International, Inc.

Global Contract Research Organization (CRO) Market - Forecast 2026-2032 | AI-Enabled Trials and Specialized Outsourcing Drive 8.89% CAGR Toward USD 135.33 Billion

globenewswire.com
CRL FTRE ICLR IQV LH TMO

Global Peripheral Blood Mononuclear Cells (PBMCs) Market to Reach $577.2 Million by 2031

globenewswire.com
TMO CRL

Global Genetic Toxicology Testing Market Size, Share, Trends, Competitive Landscape, and Forecast - 2033 | $3.6 Billion Opportunity Fueled by Automation and Outsourcing

globenewswire.com
TMO SHIM LAB DHR ILMN QGEN CRL

Global Biologics Contract Research Organizations (CRO) Market Size and Forecast, 2026-2033 | AI and Cell & Gene Therapy Outsourcing Drive 10.3% CAGR to $32.30 Billion

globenewswire.com
CRL IQV TMO

Global Animal Model Market - Share, Trends, Size, and Growth Forecasts (2026-2031) | CRISPR and Humanized Models Drive 8.24% CAGR and a USD 4.67 Billion Opportunity

globenewswire.com
CRL

High-Throughput Screening (HTS) Market by Offering, Technology, Workflow, Application, and Region - Global Forecast to 2031 | AI and Automation Fuel 10.7% CAGR to $45.90 Billion

globenewswire.com
TMO DHR BIO CC MTX CRL

Japan Cell and Gene Therapy Manufacturing Market Forecast to 2035 | Market to Reach USD 5.15 Billion at 29.0% CAGR as Commercial-Scale Capacity and Gene Therapies Expand

globenewswire.com
TMO CAT CRL AMGN BMY GILD AZN NVS MRK JNJ LLY ABBV

Global Animal Model Market Report 2026-2034 by Animal Type, Technology, Application, End User, and Region | CRISPR and Drug Discovery Drive Growth to USD 3.31 Billion

globenewswire.com
CRL

Global Drug Discovery Informatics Market Report 2026-2034 by Workflow, Function, Mode, End User, and Region | Market to Reach USD 8.44 Billion as R&D and PBPK Adoption Accelerate

globenewswire.com
ACN CRL IBM ORCL TMO

ADME Toxicology Testing Market Size, Share, Trends, and Forecast 2026-2034 | USD 30.7 Billion by 2034 at 11.2% CAGR as AI and In-Vitro Models Reshape Drug Development

globenewswire.com
AGNC DHR BIIB CRL EVTC TMO